Skip to main content

Gamunex-C News

Patients With Leukemia Have Higher Infection Risk During Immunoglobulin Replacement Therapy

THURSDAY, Aug. 7, 2025 – For patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy (IgRT) is associated with an increased incidence of...

FDA Medwatch Alert: Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions

March 10, 2025 – As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due...

FDA Medwatch Alert: Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) for Increased Reports of Allergic/Hypersensitivity Reactions

March 4, 2022 – As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Idiopathic (Immune) Thrombocytopenic Purpura

Gamunex-C patient information at Drugs.com